Drug-labels.com

Baraclude: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
0.5 mg
Active ingredient:
ATC code:

Patient Medication Information: uses, side effects, how to take - Baraclude

ABOUT THIS MEDICATION

What the medication is used for

BARACLUDE is a prescription medicine used for chronic infection with hepatitis B virus (HBV) in adults who also have active liver damage.

What it does

  • BARACLUDE may lower the amount of HBV in

    the body

  • BARACLUDE may lower the ability of HBV to

    multiply and infect new liver cells

  • BARACLUDE may reduce the damage to the liver by

    HBV

BARACLUDE will not cure HBV infection.

It is important to stay under your healthcare provider’s care while taking BARACLUDE. Your healthcare provider will test the level of the hepatitis B virus in your blood regularly.

When it should not be used

Do not take BARACLUDE if you are allergic to any of its ingredients. The active ingredient in BARACLUDE is entecavir. See “What the nonmedicinal ingredients are” for a complete list of ingredients in BARACLUDE.

Tell your healthcare provider if you think you have had an allergic reaction to any of these ingredients.

BARACLUDE has not been studied in children and is not recommended for anyone less than 16 years old.

What the medicinal ingredient is:

Entecavir

What the nonmedicinal ingredients are: BARACLUDE tablets: lactose monohydrate, microcrystalline cellulose, crospovidone, povidone, magnesium stearate, titanium dioxide, hypromellose, polyethylene glycol 400, polysorbate 80.

What dosage forms it comes in:

  • BARACLUDE film-coated tablets

Does BARACLUDE lower the risk of passing HBV to others?

BARACLUDE does not stop you from spreading HBV to others by sex, sharing needles, or being exposed to your blood. Talk to your healthcare provider about safe sexual practices that protect your partner. Never share needles. Do not share personal items that can have blood or body fluids on them, like toothbrushes or razor blades. A shot (vaccine) is available to protect people at risk from becoming infected with HBV.

WARNINGS AND PRECAUTIONS

Serious Warnings and Precautions

Severe worsening of hepatitis (liver inflammation) has occurred in patients who have stopped taking anti-hepatitis B therapy (including BARACLUDE). Your doctor will monitor your condition in this case and may resume therapy.

Lactic acidosis (increase in acid level of blood) and severe hepatomegaly with steatosis (enlarged fatty liver), including fatal cases have been reported in patients using nucleoside analogue medicines, including BARACLUDE, either alone or in combination. Reports of lactic acidosis with BARACLUDE often involved patients who were seriously ill due to their liver disease or other medical condition. Lactic acidosis is a medical emergency and must be treated in the hospital. Call your healthcare provider right away if you get any of the signs of lactic acidosis (see table Serious Side Effects and What to do About them).

Your hepatitis B infection may get worse or become very serious if you stop BARACLUDE.

  • take BARACLUDE exactly as prescribed
  • do not run out of BARACLUDE
  • do not stop BARACLUDE without talking to

    your healthcare provider

Your healthcare provider will need to monitor your health and do regular blood tests to check your liver if you stop BARACLUDE. Tell your healthcare provider right away about any new or unusual symptoms that you notice after you stop taking BARACLUDE.

If you have or get HIV (human immunodeficiency virus) infection be sure to discuss your treatment with your doctor. If you are taking BARACLUDE to treat chronic hepatitis B and are not taking medicines for your HIV at the same time, some HIV treatments that you take in the future may be less likely to work. You are advised to get an HIV test before you start taking BARACLUDE and anytime after that when there is a chance you were exposed to HIV. BARACLUDE will not help your HIV infection.

BEFORE you use BARACLUDE talk to your healthcare provider about all of your medical conditions, including if you:

  • have had a liver transplant.
  • have kidney problems. Your doctor may need to

    adjust your BARACLUDE dose or dose schedule.

  • are pregnant or planning to become pregnant. It is

    not known if BARACLUDE is safe to use during pregnancy. It is not known whether BARACLUDE helps prevent a pregnant mother from passing HBV to her baby. You and your healthcare provider will need to decide if BARACLUDE is right for you. If you use BARACLUDE while you are pregnant, talk to your healthcare provider about the BARACLUDE Pregnancy Registry.

  • are breast-feeding. It is not known if

    BARACLUDE can pass into your breast milk or if it can harm your baby. Do not breast-feed if you are taking BARACLUDE.

  • are lactose intolerant. BARACLUDE tablets

    contain lactose. If you have been told that you have intolerance to some sugars, contact your doctor before taking this medicine.

Tell your healthcare provider about all the medicines you take including prescription and non-prescription medicines, vitamins, and herbal supplements.

BARACLUDE may interact with other medicines that leave the body through the kidneys.

Know the medicines you take. Keep a list of your medicines with you to show your healthcare provider and pharmacist.

INTERACTIONS WITH THIS MEDICATION

BARACLUDE may interact with other medicines that leave the body through the kidneys.

PROPER USE OF THIS MEDICATION

Take BARACLUDE exactly as prescribed. Your healthcare provider will tell you how much BARACLUDE to take. Your dose will depend on whether you have been treated for HBV infection before and what medicine you took.

Usual dose

The usual dose of BARACLUDE Tablets in adults and children over 16 years of age is either one or two 0.5 mg tablets once daily by mouth. Your dose may be lower or you may take BARACLUDE less often than once a day, if you have kidney problems.

  • Take BARACLUDE once a day on an empty stomach to help it work better. Empty stomach means at least 2 hours after a meal and at least 2 hours before the next meal. To help you remember to take your BARACLUDE, try to take it at the same time each day.

  • Do not change your dose or stop taking

    BARACLUDE without talking to your healthcare provider. Your hepatitis B symptoms may get worse or become serious if you stop taking BARACLUDE. After you stop taking BARACLUDE, it is important to stay under your healthcare provider’s care. Your healthcare provider will need to do regular blood tests to check your liver.

  • When your supply of BARACLUDE starts to run low, get more from your healthcare provider or pharmacy. Do not run out of BARACLUDE.

Overdose

In case of drug overdosage, contact a
healthcare practitioner (e.g. doctor) hospital
emergency department or regional poison
control centre, even if there are no symptoms.

Missed Dose

If you forget to take BARACLUDE, take it as soon as you remember and then take your next dose at its regular time. If it is almost time for your next dose, skip the missed dose. Do not take two doses at the same time. Call your healthcare provider or pharmacist if you are not sure what to do.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

The most common side effects of BARACLUDE are headache, tiredness, dizziness, and nausea. Rash has also been reported. Less common side effects include diarrhea, indigestion, vomiting, sleepiness, and trouble sleeping. In some patients, the results of blood tests that measure how the liver or pancreas is working may worsen.

SERIOUS SIDE EFFECTS AND WHAT TO DO

ABOUT THEM

Symptom / effect

Talk with your

doctor or pharmacist

Stop

taking drug and call your doctor or pharmacist

Only if severeIn all cases
Lactic acidosis (high level of lactic acid in the blood) Symptoms:
Feeling very weak or tired√
Unusual (not normal) muscle pain√
Trouble breathing√
Stomach pain with nausea and vomiting√
Feeling cold especially in arms and legs√
Feeling dizzy or lightheaded√
Fast or irregular heartbeat√

Worsening hepatitis

(inflamed liver), liver

enlargement (hepatomegaly) or fatty liver Symptoms:

Skin or the white part of eyes turn yellow (jaundice)√
Dark urine√
Bowel movements (stools) turn light in colour√
Nausea√

SERIOUS SIDE EFFECTS AND WHAT TO DO

ABOUT THEM

Symptom / effect

Talk with your

doctor or pharmacist

Stop taking drug and
Lower stomach pain√call your
Loss of appetite for several days or longer√

This is not a complete list of side effects. For any unexpected effects while taking BARACLUDE, contact your doctor or pharmacist.

HOW TO STORE IT

Store BARACLUDE Tablets at room temperature, 15˚ to 30˚ C (59˚ F to 86˚ F). Keep the bottle in outer carton to protect from light. They do not require refrigeration.

Do not store BARACLUDE Tablets in a damp place such as a bathroom medicine cabinet or near the kitchen sink.

Keep the container tightly closed.

Discard BARACLUDE when it is outdated or no longer needed by returning the unused portion to your pharmacist for proper disposal.

Keep BARACLUDE and all medicines out of the reach of children and pets.

General Information

Medicines are sometimes prescribed for conditions other than those described in patient information leaflets. Do not use BARACLUDE for a condition for which it was not prescribed. Do not give BARACLUDE to other people, even if they have the same symptoms you have. It may harm them. The leaflet summarizes the most important information about BARACLUDE. If you would like more information, talk with your healthcare provider. You can also call Bristol Myers Squibb Canada at telephone number 1-866-463-6267.

REPORTING SUSPECTED SIDE EFFECTS

You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:

  • Report online at

    www.healthcanada.gc.ca/medeffect

  • Call toll-free at 1-866-234-2345
  • Complete a Canada Vigilance Reporting

    Form and:

    • Fax toll-free to 1-866-678-6789, or
    • Mail to: Canada Vigilance Program Health Canada

      Postal Locator 1908C

      Ottawa, ON K1A 0K9

Postage paid labels, Canada Vigilance Reporting Form and the adverse reactions reporting guidelines are available on the MedEffecttm Canada Web site at www.healthcanada.gc.ca/medeffect.

Note: Should you require information related to the management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

This document plus the full product monograph, prepared for health professionals, can be obtained by contacting the sponsor, Bristol-Myers Squibb Canada at 1-866-463-6267.

Last revised: 23 September 2020

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02282224

Revision date stated in the text: September 23, 2020

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Baraclude

Rx or OTC
Prescription (Rx)?
DIN 02282224
Schedule(s) PRESCRIPTION
Active ingredient(s) Entecavir 0.5 MG
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. J Antiinfectives for systemic use
    1. J05 Antivirals for systemic use
      1. J05A Direct acting antivirals
        1. J05AF Nucleoside and nucleotide reverse transcriptase inhibitors
          1. J05AF10 Entecavir
Company BRISTOL-MYERS SQUIBB CANADA
Current status Marketed
Current status date September 12, 2006

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.